By Andrea Hargraves 
MR's newsletter about medicine, innovation, mental health, business and public policy
The difference between autism and attention deficit hyperactivity disorder
Autism, or autism spectrum disorder (ASD), and ADHD, or attention-deficit hyperactivity disorder, are conditions that complicate social life and development, are difficult to diagnose, require specialized monitoring, and can vary greatly in terms of symptoms and severity between people. Individually. Diagnoses depend on clinical criteria and treatments and support requires a multidisciplinary approach.
A pediatrician specializing in autism, mental health, and neurodevelopment, Jessica Amorim Shows how to define general conditions:
Appearances
– Autism: Difficulty with communication and social interaction associated with repetitive behaviors and restricted attention patterns.
– Attention Deficit Hyperactivity Disorder: – Behavioral difficulties, impulsivity and hyperactivity.
The ages at which they appear
– Autism: Usually in the first two years of life.
– Attention Deficit Hyperactivity Disorder: It can be observed from early childhood.
attention
It is possible to simultaneously develop autism, ADHD, and other problems.
- Anxiety: People with autism often suffer from anxiety disorders.
- Depression: People with autism may also experience bouts of depression.
- Obsessive-compulsive disorder: Some people with autism may exhibit repetitive behaviors or persistent rituals characteristic of obsessive-compulsive disorder.
“It is important to recognize these comorbidities to tailor treatment strategies and improve the quality of life of people with autism,” says Jessica Amorim.
Multiple sclerosis can be detected early with a blood test
Scientists at the University of California, San Francisco have made a discovery that could make treatment for multiple sclerosis faster and more effective. People with this condition produce a range of antibodies that can be detected in the blood even before the first signs of the disease appear, and it is expected that a simple test will be able to detect MS early, giving an advantage in starting treatment. The study was published in Natural medicine.
The US Food and Drug Administration approves a drug to treat liver steatosis
The US Food and Drug Administration (FDA), the agency that regulates medicines in the United States of America, on Thursday (14) approved the first drug for a serious type of non-alcoholic fatty liver disease. Madrigal Pharmaceuticals' Resmetrum improves liver scarring in people with nonalcoholic steatohepatitis (NASH), the worst form of the disease caused by the buildup of fat in the liver.
Posted by MR
The UK will criminalize tobacco sales to people born after 2009
The Ministry of Health has expanded the use of human T-cell lymphotropic virus (HTLV) diagnostic tests in the public network. From now on, this technology will also be used in pregnant women during prenatal care. Incorporation of the test for pregnant women has been recommended by the National Committee for the Integration of Technologies into SUS (Conitec). The proposal is to reduce vertical transmission (from mother to child) of the virus during breastfeeding.
Dementia: Experts ask doctors to reduce prescribing antipsychotics
Doctors are advised to reduce prescribing antipsychotic drugs to dementia patients, after the largest study of its kind revealed that they are linked to more harmful side effects than previously thought. Strong medications are widely prescribed to treat the behavioral and psychological symptoms of dementia, such as apathy, depression, aggression, anxiety, irritability, delirium, and psychosis. The use of antipsychotics in patients with dementia was associated with a higher risk of a wide range of serious side effects, including stroke, blood clots, heart attacks, heart failure, fractures, pneumonia and acute kidney injury, the study authors reported. The results were published in the scientific journal BMJ.
HTLV testing is now recommended for pregnant women during prenatal care
The Ministry of Health has expanded the use of human T-cell lymphotropic virus (HTLV) diagnostic tests in the public network. From now on, this technology will also be used in pregnant women, during prenatal care. The National Technology Integration Committee of SUS (Conitec) has recommended integrating the test for pregnant women. The proposal is to reduce vertical transmission (from mother to child) of the virus during breastfeeding.